Date: 2016-11-16
Type of information: Nomination
Compound:
Company: Gilead Sciences (USA - CA)
Therapeutic area: Infectious diseases - Cancer - Oncology - Hepatic diseases - Liver diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On November 16, 2016, Gilead Sciences announced the promotion of James R. Meyers to Executive Vice President, Worldwide Commercial Operations, with responsibility for commercial operations in North America , Europe and Japan . Mr. Meyers will become an officer of the company and member of Gilead's senior leadership team. Mr. Meyers joined Gilead in 1996 as a regional sales director and has been the Senior Vice President of North American Commercial Operations since 2007. In his 20 years at Gilead, Mr. Meyers has been instrumental in building out the company's commercial operations in North America , including leading successful product launches in HIV, oncology, cardiovascular, respiratory and liver diseases. Prior to Gilead, Mr. Meyers held positions of increasing responsibility in sales, training, marketing and management with Zeneca Pharmaceuticals and Astra USA. He received his Bachelor's degree in economics from Boston College .
Financial terms:
Latest news:
